NK

Nilesh Krishanat Mane

Active Director Director DIN 10639607
DIN 10639607 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Nilesh Krishanat Mane

Data last updated:

Nilesh Krishanat Mane is a Director at Sunfinity Life Science Private Limited (since 2024).

DIN 10639607
Primary Designation Director
First Appointment 07 Jun 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jun 20242023Active

Directorship timeline

Open interactive timeline →
Sunfinity Life Science Private Limited
Premium access

Shareholding and investment profile for Nilesh Krishanat Mane

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilesh Krishanat Mane

Nilesh Krishanat Mane currently holds 1 directorship: Sunfinity Life Science Private Limited (Director, since 07 Jun 2024).

Nilesh Krishanat Mane was first appointed on 07 Jun 2024 as Director at Sunfinity Life Science Private Limited.

The current boards of Nilesh Krishanat Mane's companies include Abhijit Gunderao Patil (Sunfinity Life Science Private Limited), Amit Govind Narvekar (Sunfinity Life Science Private Limited), Kiran Panditrao Patil (Sunfinity Life Science Private Limited), Nilesh Pandurang Patil (Sunfinity Life Science Private Limited), Raisa Suhel Shaikh (Sunfinity Life Science Private Limited), Sarika Vikas Patil (Sunfinity Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available